(Q50243071)

28 February 2018

title

Can we deliver randomized trials of focal therapy in prostate cancer? (English)

1 reference

28 February 2018

Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?

1 reference

corrigendum / erratum

0 references

author

Clare Relton

9

1 reference

28 February 2018

Matthew R Sydes

11

1 reference

28 February 2018

Andrew Vickers

14

1 reference

28 February 2018

Tom Leslie

object named as

Tom Leslie

7

0 references

Mark Emberton

16

object named as

Mark Emberton

1 reference

28 February 2018

Hashim U Ahmed

1

1 reference

28 February 2018

Viktor Berge

2

1 reference

28 February 2018

David Bottomley

3

1 reference

28 February 2018

William Cross

4

1 reference

28 February 2018

Rakesh Heer

5

1 reference

28 February 2018

Richard Kaplan

6

1 reference

28 February 2018

Chris Parker

8

1 reference

28 February 2018

Richard Stephens

10

1 reference

28 February 2018

Lindsay Turnbull

12

1 reference

28 February 2018

Jan van der Meulen

13

1 reference

28 February 2018

Timothy Wilt

15

1 reference

28 February 2018

Prostate Cancer RCT Consensus Group

17

1 reference

28 February 2018

language of work or name

English

0 references

publication date

22 April 2014

1 reference

28 February 2018

Nature Reviews Clinical Oncology

published in

1 reference

28 February 2018

volume

11

1 reference

28 February 2018

issue

8

1 reference

28 February 2018

page(s)

482-491

1 reference

28 February 2018

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2014.44

exact match

0 references

cites work

Prostate cancer screening and the management of clinically localized disease

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Radical prostatectomy versus observation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Long-term functional outcomes after treatment for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Will focal therapy become a standard of care for men with localized prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Correlation of magnetic resonance imaging tumor volume with histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

The PICTURE study -- prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Focal therapy for localized prostate cancer: a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Image guided photothermal focal therapy for localized prostate cancer: phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

MR imaging-guided focal laser ablation for prostate cancer: phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Tumor focality in prostate cancer: implications for focal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

A biomedical engineering approach to mitigate the errors of prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

MRI-targeted prostate biopsy: a review of technique and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Developing core outcome sets for clinical trials: issues to consider

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Interpreting composite outcomes in trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Incidence of bone metastases in breast cancer patients in the United Kingdom: results of a multi-database linkage study using the general practice research database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Southwest Oncology Group strategies in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Few patients with prostate cancer are willing to be randomised to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be diffic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Increasing value and reducing waste in biomedical research regulation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

South Yorkshire Cohort: a 'cohort trials facility' study of health and weight - protocol for the recruitment phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Randomised consent designs in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Challenges in evaluating surgical innovation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Radical prostatectomy versus watchful waiting in early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

The index lesion and the origin of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

The role of focal therapy in the management of localised prostate cancer: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Dynamic Contrast-enhanced–magnetic Resonance Imaging Evaluation of Intraprostatic Prostate Cancer: Correlation with Radical Prostatectomy Specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: a comparison with radical prostatectomy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Characterizing clinically significant prostate cancer using template prostate mapping biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Diagnostic tests in urology: magnetic resonance imaging (MRI) for the staging of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Prostate biopsy in selecting candidates for hemiablative focal therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Driving up the quality and relevance of research through the use of agreed core outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Early closure of a randomized controlled trial of three treatment approaches to early localised prostate cancer: the MRC PR06 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Prostate cancer--uncertainty and a way forward

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.44

Pathology of prostate cancer and focal therapy ('male lumpectomy').

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24751803

12 December 2020

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/24751803

12 December 2020

inferred from PubMed ID database lookup

New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24751803

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRCLINONC.2014.44

1 reference

28 February 2018

Dimensions Publication ID

1035395995

0 references

Fatcat ID

release_2xyxdezuljexrdlxfsafj2yidm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2xyxdezuljexrdlxfsafj2yidm

24 November 2022

mapped directly with Wikidata item

1 reference

28 February 2018